Scroll To Top
Search by Speciality


JW Marriott parq Vancouver | Vancouver , USA
From 450 to 550 USD
Event Preview
This event
is Finished
Specialty: Rheumatology
Dates: From Feb, 21, 2018 to Feb, 24, 2018
Location: Vancouver , USA
Type: Meeting
Registration Cost: From 450 to 550 USD
Event Tools
  • Add to Favorites
  • Claim this event
Add to my Calendar
  • Scientific Programm
  • Online registration
  • Exhibition floorplans
  • Sponsorship &
    Exhibition consensus
  • Virtual Booths
Weather Info (monthly averages) Max Temperature: C / F Min Temperature: C / F The above data in our Weather Info table are temperature predictions for the date of the medical event for VANCOUVER , Usa.
General Info
Event Venue:

JW Marriott parq Vancouver

VANCOUVER , USA Visit the Venue to read more


Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credit to AMA credit can be found at


Live educational activities, occurring in Canada, recognized by the Royal College of Physicians and Surgeons of Canada as Accredited Group Learning Activities (Section 1) are deemed by the European Union of Medical Specialists (UEMS) eligible for ECMEC®.

Concerned Audience:
  • Medical_Professionals
  • Medical_students
  • Nurses
Event Overview
Welcome message:

Precision & Personalized Medicine in Rheumatology is the theme for this year’s annual meeting in beautiful Vancouver at The Douglas!

We are thrilled to announce our speaker line-up of Dr. Ranjeny Thomas and Dr. Linda Li as keynote speakers as well as Dr. Marvin Fritzler as our Dunlop-Dottridge lecturer. 

Professor Ranjeny Thomas is the Arthritis Queensland Chair in Rheumatology at the University of Queensland Diamantina Institute in Australia. Professor Thomas’ work is focused on studying the biology of human dendritic cells in autoimmune diseases and their clinical application for treatments. Professor Thomas is known for her contributions to the field of immune tolerance and risk factors for rheumatoid arthritis and type I diabetes. This has led to an antigen-specific vaccine to treat rheumatoid arthritis, which is currently in clinical trials, a therapeutic platform for antigen-specific immunotherapy, and a new diagnostic test and immunotherapy for type I diabetes. She is also the founder and director of a spin-off company, Dendright, managing the development of vaccines to suppress autoimmune diseases.

Professor Linda Li is the Harold Robinson/Arthritis Society Chair in Arthritic Diseases, and Canada Research Chair in Patient-Oriented Knowledge Translation at the Department of Physical Therapy, University of British Columbia. She is also a Senior Scientist at the Arthritis Research Canada. Dr. Li’s research focus includes understanding the help-seeking experiences of people with early inflammatory arthritis and evaluating models of arthritis care. A key interest of hers, which ties in well to our meeting theme of Precision & Personalized Medicine in Rheumatology, is her collaborative efforts with digital media experts to develop and evaluate electronic tools for shared decision-making between clinicians and patients. She has been recognized for her outstanding work in the arthritis field with the Michael Smith Foundation Health Research Career Investigator award, among many others.

Professor Marvin Fritzler is a prominent Canadian Rheumatologist, recognized internationally for his contributions to the field of rheumatology by improving the diagnosis of autoimmune diseases. He was inducted as a Master of the American College of Rheumatology in 2013, ten years after being recognized by the CRA with the designation of Scientist of the Year. Dr. Fritzler has served as Chair of the Alberta Research and Innovation Authority. He has published over 420 peer-reviewed manuscripts with more than eleven thousand citations. For his work in molecular diagnostics with autoantibodies, which underpin the precise diagnosis of several autoimmune conditions, Dr. Fritzler recently received the Carl R Jolliff Award for Lifetime Achievement in Clinical and Diagnostic Immunology from the American Association of Clinical Chemistry. It is a tremendous pleasure to welcome him back this year as the CRA’s 2017 Dunlop Dottridge Lecturer.

This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of The Royal College of Physicians and Surgeons of Canada, and approved by the Canadian Rheumatology Association.


Marvin J Fritzler, PhD, MD

Professor, Cumming School of Medicine

Director, Mitogen Advanced Diagnostics, University of Calgary

Professor Marvin Fritzler received his PhD in 1971 and MD in 1974 from the University of Calgary. He went to The Scripps Research Institute in La Jolla, Californa and then to the University of Colorado as a research fellow under the mentorship of Dr. Eng M. Tan. After a post-doctoral fellowship at the University of Colorado, he joined the University of Calgary in 1978 where he is currently Professor in the Cumming School of Medicine. His clinical and research activity is devoted to biomarker identification and autoantibody testing.  From 2001 to 2015, he served as Chair of the Alberta Research and Innovation Authority, a strategic policy advisory board of the Government of Alberta. He has published over 420 peer-reviewed manuscripts and has over 11,000 citations. He has received numerous awards including Canadian Rheumatology Association Scientist of the Year (2003), Master of the American College of Rheumatology (2013), Order of the University of Calgary (2014), and Carl R Jolliff Award for Lifetime Achievement in Clinical and Diagnostic Immunology from the American Association of Clinical Chemistry (2016). He is the Director of Mitogen International Advanced Diagnostics in Calgary, Alberta. 

Keynote Lecture

Immunotherapy: Immune Modulation to Cure RA

Ranjeny Thomas, MBBS (WA), MD (WA), FRACP, FAAHMS

Professor of Rheumatology, University of Queensland, Translational Research Institute

Consultant Rheumatologist, Princess Alexandra Hospital

Fellow, Australian Academy of Health and Medical Sciences

Professor Thomas' research seeks to understand autoimmune disease and restoration of immune tolerance. Through this work, she developed and tested the first rheumatoid arthritis vaccine. She has also contributed major insights into how the microbiome is involved in causing spondyloarthropathy leading to the development of disease biomarkers and therapeutic strategies. Ranjeny is founder and a director of the spin-off company, Dendright, which is developing immunotherapy for autoimmune diseases. 

Arthritis Care in the Digital Age: The Patient CAN See You Now


Linda Li, BSc(PT), MSc, PhD

Harold Robinson Chair / Arthritis Society Chair in Arthritic Diseases

Associate Professor, Department of Physical Therapy, University of British Columbia

Professor Li is Harold Robinson / Arthritis Society Chair at the Department of Physical Therapy, University of British Columbia, and Senior Research Scientist at Arthritis Research Canada. She holds a Canada Research Chair in Patient-oriented Knowledge Translation.

Professor Li’s research focuses on understanding the help-seeking experience of people with arthritis, evaluating the use of models of care, and more recently, studying the experience and benefits of patient engagement in research. She collaborates with digital media experts to create and evaluate online tools, such as patient decision aids for promoting shared-decision making and interactive programs to support an active lifestyle. In 2015, Professor Li was awarded the Distinguished Scholar Award by the Association of Rheumatology Health Professionals (a division of American College of Rheumatology) for her achievements in scholarly activities pertinent to arthritis and rheumatic diseases.

Registration Needs updating Register Now


Registration Cost
Early Registration

Late Registration From: 2017-09-19 To: 0--
On site Registration

Group Registrations:

Group registrations not allowed

Accompanying Persons:

Accompanying persons not allowed

Registration Documents:
Letter of invitation:
We don’t provide letter of invitation
Letter of confirmation:
We don’t provide Letter of Confirmation
Proof of professional / educational status:
We don’t need Proof of professional/educational status
Online Abstract Submission:

We don’t accept Online Abstracts


JW Marriott parq Vancouver & the DOUGLAS

39 Smithe Street  

Vancouver, British Columbia  V6B 1C1


Accommodation Options and Cost

Hotel Name
Type of charge
Distance from Venue
JW Marriott
Date range
Further Details:
The Hotel’s check-in and check-out time are 4:00pm and 12:00pm respectively.  Guests are permitted to check in early or check out later subject to room availability with no additional charge. The Hotel will charge a one-time fee of $100 to any attendee for early departures (after guests check into Hotel).
Scientific Content Up to Date
Submission Info

Attendees at the 2018 Canadian Rheumatology Association (CRA) Annual Scientific Meeting (ASM) and the Arthritis Health Professions Association (AHPA) Annual Meeting are invited to submit abstracts for presentation during the meeting.  We encourage you to submit abstracts relating to original research, systematic reviews or meta-analyses. Case reports or case series are acceptable. Project proposals without data or results will not be accepted. Abstracts may be presented at one meeting prior to the CRA ASM but data cannot be published before the CRA ASM. Abstracts cannot be submitted on data that has already been accepted for publication as a manuscript (publication in abstract form from a conference presentation is acceptable).

During the on-line submission process, you will be asked to enter the first author, the first author’s contact information, and the names and e-mail addresses of all co-authors (as well as the email of an optional additional correspondent, i.e. Submitter).

Please ensure the e-mail address of the corresponding author is accurate, as this will be the sole method of communication regarding acceptance.

There is a limit of 400 words for each abstract. This does not include abstract title and author names. Longer submissions will be cut off at the word limit.

All submissions must be input (typed or copied) into the correct fields (Objectives, Methods, Results and Conclusion).  There is no uploading of abstract files.

No tables or graphs will be accepted.

Each page of the submission process is automatically saved.

You will receive an e-mail confirmation for each submission.

Abstract submission deadline 2017-10-16
Sponsors Exhibitors
General Info

, Canadian Rheumatology Association

Phone: 905-952-0698


Organising Agency

, Canadian Rheumatology Association

Phone: 905-952-0698


Event map
Revelant Events